CAAR Delhi Rules on Classification of BD ViperTM LT System: Heading 9031 vs Heading 9027

1. Background of the Advance Ruling

M/s Becton Dickinson India Private Limited approached the Customs Authority for Advance Rulings, New Delhi under Section 28-H of the Customs Act, 1962 seeking clarity on the customs classification and applicable duty structure for an automated diagnostic platform, BD ViperTM LT System, imported for use in cervical cancer screening.

The assessee initially classified the product under Heading 9031 on a provisional basis but later contended that a more specific classification was available under Heading 9027 as an instrument for chemical analysis. The jurisdictional Commissionerate, however, favoured classification under Heading 9031, covering other measuring or checking instruments.

The ruling therefore turned on two principal questions:

  1. Whether BD ViperTM LT System is classifiable under Customs Tariff Item 9027 50 90 or 9027 89 90 or instead under 9031 49 00; and
  2. What rate of Basic Customs Duty (BCD) and Import IGST would apply on such imports.

The Authority examined the technical features of the equipment, the General Rules for Interpretation (GRI), relevant Section and Chapter Notes of the Customs Tariff, and the HSN Explanatory Notes before issuing its decision.

2. Product Description and Functional Overview

2.1 Nature and Intended Use

The BD ViperTM LT System is an automated real-time PCR-based in-vitro diagnostic instrument. It is intended to be used in clinical laboratories together with specific in-vitro diagnostic (IVD) assays (such as BD OnclarityTM HPV Assay) for:

  • Extraction of nucleic acids from clinical specimens
  • Amplification of specific nucleic acid targets
  • Detection of high-risk HPV DNA for cervical cancer screening and related risk assessment

The system does not operate independently as a general-purpose analyzer; rather, it is used in conjunction with designated assay kits designed for the qualitative detection of certain high-risk HPV genotypes.

2.2 Major Components

The machine is a composite, integrated system comprising multiple modules, including:

  • Temperature control and heating sub-system for onboard heaters
  • Robotic pipetting arm for automated sample transfer, tube puncturing and sealing
  • DNA extraction module using chemical processes and magnetic particles
  • Optical reader for fluorescence-based detection of amplification reactions
  • Touchscreen LCD monitor for user interaction
  • Central processing unit managing instrument control, self-calibration and user interface

2.3 Operational Workflow

In simplified form, the BD ViperTM LT System carries out the following sequential processes:

  1. Specimen preparation and pre-warming

    • Clinical samples (e.g., cervical or vaginal swabs) are placed into specimen tubes held in racks.
    • The rack is pre-warmed to facilitate lysis and homogenization as per the assay type.

  2. Transfer to extraction tubes

    • A robotic arm aspirates measured volumes of sample and dispenses them into specially designed extraction tubes containing ferric oxide particles enclosed in a dissolvable film.

  3. Chemical extraction and purification of DNA

    • Alkaline solution is added to lyse cells and release DNA.
    • Acidification induces a positive charge on ferric oxide, allowing binding of negatively charged DNA.
    • Unbound impurities are removed; the bound DNA is washed and then released into solution using a high-pH elution buffer, yielding purified DNA.

  4. Loading into reaction wells/tubes

    • The purified DNA is pipetted into PCR tubes or priming wells already containing dried primers, fluorescent-labelled probes, enzymes (such as Taq polymerase) and ancillary reagents.
    • The wells/tubes are sealed and transferred to the reader module.

  5. Amplification and fluorescence detection

    • The instrument executes a programmed PCR protocol using a Peltier-based thermocycler.
    • High-intensity LEDs emit visible light (approx. 460–670 nm) to excite fluorescent dyes; emission is captured by a CCD camera through optical filters.
    • A software algorithm evaluates fluorescence signals in real time and generates a positive/negative diagnostic result, indicating whether target HPV DNA is present in the specimen.

The system thus executes a pre-set protocol, transforming clinical samples into a binary diagnostic outcome based on fluorescence signalling linked to target DNA amplification.

3. Assessee’s Arguments for Classification under Heading 9027

3.1 Reliance on CTH 9027 as “Instrument for Physical or Chemical Analysis”

The assessee maintained that the BD ViperTM LT System qualifies as an instrument or apparatus for chemical analysis within the meaning of Heading 9027, which covers, inter alia:

“Instruments and apparatus for physical or chemical analysis (for example, Polarimeters, Refractometers, Spectrometers, Gas or Smoke Analysis Apparatus)…”

Key contentions included:

  • The device performs chemical analysis by subjecting specimens to defined chemical reactions (lysis, binding to ferric oxide, washing, elution, PCR amplification) to identify the presence of HPV DNA.
  • The integrated platform is therefore an “instrument or apparatus” designed to conduct chemical analysis of clinical specimens.
  • The HSN Explanatory Notes to Heading 9027, particularly item 33, explicitly refer to “Instruments and apparatus used in clinical laboratories for in vitro diagnostic testing”, which were argued to encompass the BD ViperTM LT System.

3.2 Conceptual Basis: “Chemical Analysis” and “Physical Analysis”

The assessee drew on dictionary and legal definitions to argue:

  • Chemical analysis involves determining the composition, nature or concentration of substances through chemical reactions or interactions with energy (light, electricity etc.).
  • Physical analysis concerns determination of non-chemical properties such as viscosity, density, melting point, etc.